FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200399062> ?p ?o ?g. }

• W4200399062 endingPage "642" @default.
• W4200399062 startingPage "637" @default.
• W4200399062 abstract "The echinoderm microtubule associated protein-like 4 gene (EML4) encodes the predominant anaplastic lymphoma kinase (ALK) fusion partner in non-small-cell lung cancer (NSCLC); however, the dynactin subunit 1 (DCTN1)-ALK rearrangement is extremely rare. The co-occurrence of primary epidermal growth factor receptor (EGFR) T790M mutation with EGFR exon 19 deletion (del) in patients with NSCLC is uncommon. Here we report a female lung adenocarcinoma patient with brain metastases and possible coexistence of primary EGFR T790M mutation/EGFR exon 19 del/DCTN1-ALK translocation. The patient received multiline treatment including chemotherapy, antivascular, and targeted therapies. To overcome developed resistance to chemotherapy or targeted therapy to prolong overall survival, the patient's circulating tumor DNA (ctDNA) was dynamically monitored. The patient responded to successive osimertinib and alectinib treatment, and alectinib achieved a nearly complete response for lung and brain lesions after she acquired osimertinib resistance. Furthermore, we summarize 22 published cases of patients with lung adenocarcinoma with concurrent EGFR mutation and ALK rearrangement, including details of clinical characteristics, natural history, and pertinent therapy of this uncommon tumor subtype. This literature review shows that EGFR inhibition was an indispensable aspect of the treatment of patients with EGFR/ALK co-alterations in the pre-alectinib era and that ALK inhibition with crizotinib did not show more eye-catching therapeutic results. Considering the effectiveness achieved by alectinib, this case study provides a new perspective for the treatment of lung cancer brain metastasis patients with concurrent EGFR/ALK mutations." @default.
• W4200399062 created "2021-12-31" @default.
• W4200399062 creator A5003378386 @default.
• W4200399062 creator A5035220232 @default.
• W4200399062 creator A5035272423 @default.
• W4200399062 creator A5038151589 @default.
• W4200399062 creator A5076606324 @default.
• W4200399062 creator A5090889094 @default.
• W4200399062 creator A5091071584 @default.
• W4200399062 date "2021-12-28" @default.
• W4200399062 modified "2023-09-28" @default.
• W4200399062 title "Effectiveness of alectinib and osimertinib in a brain metastasized lung adenocarcinoma patient with concurrent <scp> <i>EGFR</i> </scp> mutations and <scp> <i>DCTN1‐ALK</i> </scp> fusion" @default.
• W4200399062 cites W1939507216 @default.
• W4200399062 cites W1942770305 @default.
• W4200399062 cites W1967054188 @default.
• W4200399062 cites W1990875825 @default.
• W4200399062 cites W1996244557 @default.
• W4200399062 cites W2054711484 @default.
• W4200399062 cites W2055402151 @default.
• W4200399062 cites W2060575051 @default.
• W4200399062 cites W2070971017 @default.
• W4200399062 cites W2083544525 @default.
• W4200399062 cites W2126927831 @default.
• W4200399062 cites W2154149901 @default.
• W4200399062 cites W2166419674 @default.
• W4200399062 cites W2263144737 @default.
• W4200399062 cites W2558415788 @default.
• W4200399062 cites W2690078869 @default.
• W4200399062 cites W2734470318 @default.
• W4200399062 cites W2749372468 @default.
• W4200399062 cites W2750470513 @default.
• W4200399062 cites W2791917433 @default.
• W4200399062 cites W2903120675 @default.
• W4200399062 cites W2919601798 @default.
• W4200399062 cites W2922780430 @default.
• W4200399062 cites W3001100920 @default.
• W4200399062 cites W4200399062 @default.
• W4200399062 doi "https://doi.org/10.1111/1759-7714.14291" @default.
• W4200399062 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34964276" @default.
• W4200399062 hasPublicationYear "2021" @default.
• W4200399062 type Work @default.
• W4200399062 citedByCount "4" @default.
• W4200399062 countsByYear W42003990622021 @default.
• W4200399062 countsByYear W42003990622022 @default.
• W4200399062 crossrefType "journal-article" @default.
• W4200399062 hasAuthorship W4200399062A5003378386 @default.
• W4200399062 hasAuthorship W4200399062A5035220232 @default.
• W4200399062 hasAuthorship W4200399062A5035272423 @default.
• W4200399062 hasAuthorship W4200399062A5038151589 @default.
• W4200399062 hasAuthorship W4200399062A5076606324 @default.
• W4200399062 hasAuthorship W4200399062A5090889094 @default.
• W4200399062 hasAuthorship W4200399062A5091071584 @default.
• W4200399062 hasBestOaLocation W42003990623 @default.
• W4200399062 hasConcept C117643217 @default.
• W4200399062 hasConcept C121608353 @default.
• W4200399062 hasConcept C126322002 @default.
• W4200399062 hasConcept C142724271 @default.
• W4200399062 hasConcept C143998085 @default.
• W4200399062 hasConcept C2776232967 @default.
• W4200399062 hasConcept C2776256026 @default.
• W4200399062 hasConcept C2777626846 @default.
• W4200399062 hasConcept C2777930144 @default.
• W4200399062 hasConcept C2778087573 @default.
• W4200399062 hasConcept C2778164965 @default.
• W4200399062 hasConcept C2779013556 @default.
• W4200399062 hasConcept C2779220645 @default.
• W4200399062 hasConcept C2779422266 @default.
• W4200399062 hasConcept C2779438470 @default.
• W4200399062 hasConcept C2779750558 @default.
• W4200399062 hasConcept C2780580887 @default.
• W4200399062 hasConcept C2781182431 @default.
• W4200399062 hasConcept C2781230642 @default.
• W4200399062 hasConcept C502942594 @default.
• W4200399062 hasConcept C71924100 @default.
• W4200399062 hasConceptScore W4200399062C117643217 @default.
• W4200399062 hasConceptScore W4200399062C121608353 @default.
• W4200399062 hasConceptScore W4200399062C126322002 @default.
• W4200399062 hasConceptScore W4200399062C142724271 @default.
• W4200399062 hasConceptScore W4200399062C143998085 @default.
• W4200399062 hasConceptScore W4200399062C2776232967 @default.
• W4200399062 hasConceptScore W4200399062C2776256026 @default.
• W4200399062 hasConceptScore W4200399062C2777626846 @default.
• W4200399062 hasConceptScore W4200399062C2777930144 @default.
• W4200399062 hasConceptScore W4200399062C2778087573 @default.
• W4200399062 hasConceptScore W4200399062C2778164965 @default.
• W4200399062 hasConceptScore W4200399062C2779013556 @default.
• W4200399062 hasConceptScore W4200399062C2779220645 @default.
• W4200399062 hasConceptScore W4200399062C2779422266 @default.
• W4200399062 hasConceptScore W4200399062C2779438470 @default.
• W4200399062 hasConceptScore W4200399062C2779750558 @default.
• W4200399062 hasConceptScore W4200399062C2780580887 @default.
• W4200399062 hasConceptScore W4200399062C2781182431 @default.
• W4200399062 hasConceptScore W4200399062C2781230642 @default.
• W4200399062 hasConceptScore W4200399062C502942594 @default.
• W4200399062 hasConceptScore W4200399062C71924100 @default.
• W4200399062 hasFunder F4320321001 @default.
• W4200399062 hasIssue "4" @default.
• W4200399062 hasLocation W42003990621 @default.

• next